New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Anixa Biosciences, Inc.
ANIX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

105M

Biotechnology

Next Earning date - 21 Jan 2025

105M

Biotechnology

Next Earning date - 21 Jan 2025

3.25USD
Shape0.10 ( 3.17%)
favorite-chart

Relative Strenght

16
favorite-chart

Volume Buzz

17%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

37%

Quote Panel

Shape
Updated October 26, 2024
1W 6.54 % 1M 2.19 % 3M 6.89 % 1Y 7.24 %

Key Metrics

Shape
  • Market Cap

    104.58M


  • Shares Outstanding

    32.18M


  • Share in Float

    30.56M


  • Dividende

    0


  • Earning Date

    21 Jan 2025


  • Price Target

    3.25


  • Average Volume

    66335


  • Beta

    0.863


  • Range

    2.15-5.13


  • Industry

    Biotechnology


  • Website

    https://www.anixa.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

670.41x

P/S Ratio

4.79x

P/B Ratio

0.0

Debt/Equity

-7923.7%

Net Margin

$-0.4

EPS

How ANIX compares to sector?

P/E Ratio

Relative Strength

Shape

ANIX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$120M

ShapeNaN%

2025-Revenue

$0.36

Shape-265%

2025-EPS

$48M

Shape-1241%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

EF Hutton

initialise

Previous: Not converted

2024-08-07

Now: Buy

Chardan Capital

initialise

Previous: Not converted

2022-12-23

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.12
vs -0.13

Q1.23

arrow
arrow

N/A

-0.08
vs -0.13

Q2.23

arrow
arrow

N/A

-0.07
vs -0.12

Q3.23

arrow
arrow

N/A

-0.08
vs -0.09

Q4.23

arrow
arrow

N/A

-0.09
vs -0.12

Q1.24

arrow
arrow

N/A

-0.10
vs -0.08

Q2.24

arrow
arrow

N/A

-0.10
vs -0.07

Q3.24

arrow
arrow

N/A

-0.10
vs -0.08

Q4.24

arrow
arrow

N/A

-0.09
vs -0.09

Q1.25

arrow
arrow

N/A

-0.09
vs -0.10

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

+68227%

2.5B  vs 3.6M

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

210K  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

-100%

156K  vs 2.5B

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

-100%

NA  vs 210K

Q3.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-12%

-0.12
vs -0.09

Q1.23

arrow
arrow

-8%

-0.08
vs -0.12

Q2.23

arrow
arrow

-8%

-0.08
vs -0.08

Q3.23

arrow
arrow

-10%

-0.10
vs -0.08

Q4.23

arrow
arrow

-11%

-0.11
vs -0.10

Q1.24

arrow
arrow

-13%

-0.13
vs -0.11

Q2.24

arrow
arrow

-13%

-0.13
vs -0.13

Q3.24

arrow
arrow

-15%

-0.15
vs -0.13

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

42

42
vs 47

-11%

Q4.22

arrow
arrow

52

52
vs 42

24%

Q1.23

arrow
arrow

46

46
vs 52

-12%

Q2.23

arrow
arrow

47

47
vs 46

2%

Q3.23

arrow
arrow

52

52
vs 47

11%

Q4.23

arrow
arrow

58

58
vs 52

12%

Q1.24

arrow
arrow

60

60
vs 58

3%

Q2.24

arrow
arrow

51

51
vs 60

-15%

Earnings Growth

Latest News